These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Velasco G; Campo M; Manrique OJ; Bellou A; He H; Arestides RS; Schaub B; Perkins DL; Finn PW Am J Respir Cell Mol Biol; 2005 Mar; 32(3):218-24. PubMed ID: 15576672 [TBL] [Abstract][Full Text] [Related]
7. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus. Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor (TLR) 7 decreases and TLR9 increases the airway responses in mice with established allergic inflammation. Adner M; Starkhammar M; Georén SK; Dahlén SE; Cardell LO Eur J Pharmacol; 2013 Oct; 718(1-3):544-51. PubMed ID: 24041926 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice. Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818 [TBL] [Abstract][Full Text] [Related]
10. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment. Duechs MJ; Tilp C; Tomsic C; Gantner F; Erb KJ PLoS One; 2014; 9(3):e91223. PubMed ID: 24618687 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. Kaiko GE; Loh Z; Spann K; Lynch JP; Lalwani A; Zheng Z; Davidson S; Uematsu S; Akira S; Hayball J; Diener KR; Baines KJ; Simpson JL; Foster PS; Phipps S J Allergy Clin Immunol; 2013 May; 131(5):1331-9.e10. PubMed ID: 23561801 [TBL] [Abstract][Full Text] [Related]
13. Bacillus-derived poly-γ-glutamic acid attenuates allergic airway inflammation through a Toll-like receptor-4-dependent pathway in a murine model of asthma. Lee K; Kim SH; Yoon HJ; Paik DJ; Kim JM; Youn J Clin Exp Allergy; 2011 Aug; 41(8):1143-56. PubMed ID: 21672055 [TBL] [Abstract][Full Text] [Related]
14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [TBL] [Abstract][Full Text] [Related]
15. Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10. Tournoy KG; Kips JC; Pauwels RA J Allergy Clin Immunol; 2001 Mar; 107(3):483-91. PubMed ID: 11240949 [TBL] [Abstract][Full Text] [Related]
16. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. Grela F; Aumeunier A; Bardel E; Van LP; Bourgeois E; Vanoirbeek J; Leite-de-Moraes M; Schneider E; Dy M; Herbelin A; Thieblemont N J Immunol; 2011 Jan; 186(1):284-90. PubMed ID: 21131420 [TBL] [Abstract][Full Text] [Related]
17. Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms. Van LP; Bardel E; Gregoire S; Vanoirbeek J; Schneider E; Dy M; Thieblemont N Eur J Immunol; 2011 Jul; 41(7):1992-9. PubMed ID: 21480211 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Hatchwell L; Collison A; Girkin J; Parsons K; Li J; Zhang J; Phipps S; Knight D; Bartlett NW; Johnston SL; Foster PS; Wark PA; Mattes J Thorax; 2015 Sep; 70(9):854-61. PubMed ID: 26108570 [TBL] [Abstract][Full Text] [Related]
19. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses. Phipps S; Lam CE; Kaiko GE; Foo SY; Collison A; Mattes J; Barry J; Davidson S; Oreo K; Smith L; Mansell A; Matthaei KI; Foster PS Am J Respir Crit Care Med; 2009 May; 179(10):883-93. PubMed ID: 19246719 [TBL] [Abstract][Full Text] [Related]
20. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]